These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37867242)

  • 21. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
    Wymore Brand M; Anderson TK; Kitikoon P; Brian Kimble J; Otis N; Gauger PC; Souza CK; Kaplan B; Mogler M; Strait E; Vincent Baker AL
    Vaccine; 2022 Sep; 40(38):5569-5578. PubMed ID: 35987871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an Attenuated Chimeric Bat Influenza A Virus Live-Vaccine Prototype.
    Ran W; Schön J; Ciminski K; Kraft J; Kessler S; Euchner S; Hoffmann D; Pohlmann A; Beer M; Schwemmle M; Giese S
    Microbiol Spectr; 2022 Dec; 10(6):e0142422. PubMed ID: 36445145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
    Matsuoka Y; Suguitan A; Orandle M; Paskel M; Boonnak K; Gardner DJ; Feldmann F; Feldmann H; Marino M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Jul; 88(14):8139-52. PubMed ID: 24807726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes.
    Nogales A; Schotsaert M; Rathnasinghe R; DeDiego ML; García-Sastre A; Martinez-Sobrido L
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
    Rowell J; Lo CY; Price GE; Misplon JA; Crim RL; Jayanti P; Beeler J; Epstein SL
    PLoS One; 2019; 14(4):e0215321. PubMed ID: 30986224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.
    do Nascimento GM; Bugybayeva D; Patil V; Schrock J; Yadagiri G; Renukaradhya GJ; Diel DG
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine.
    Joshi LR; Knudsen D; Piñeyro P; Dhakal S; Renukaradhya GJ; Diel DG
    Front Immunol; 2021; 12():747574. PubMed ID: 34804030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
    Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early vaccine-mediated strain-specific cytokine imbalance induces mild immunopathology during influenza infection.
    Bull MB; Ma FN; Perera LP; Poon LL; Valkenburg SA
    Immunol Cell Biol; 2023 Jul; 101(6):514-524. PubMed ID: 36401824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.
    Wang S; Chi X; Wei H; Chen Y; Chen Z; Huang S; Chen JL
    J Virol; 2014 Aug; 88(15):8375-85. PubMed ID: 24829357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions.
    Hsu AC
    Front Immunol; 2018; 9():743. PubMed ID: 29755452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
    Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
    Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza A Virus Studies in a Mouse Model of Infection.
    Rodriguez L; Nogales A; Martínez-Sobrido L
    J Vis Exp; 2017 Sep; (127):. PubMed ID: 28930978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.